{"id":7348,"date":"2021-10-22T13:21:30","date_gmt":"2021-10-22T12:21:30","guid":{"rendered":"https:\/\/www.thervacb.eu\/patienten-2\/der-thervacb-impfstoff\/"},"modified":"2025-07-15T08:40:57","modified_gmt":"2025-07-15T07:40:57","slug":"der-thervacb-impfstoff","status":"publish","type":"page","link":"https:\/\/www.thervacb.eu\/de\/patienten\/der-thervacb-impfstoff\/","title":{"rendered":"Der TherVacB-Impfstoff"},"content":{"rendered":"

[et_pb_section fb_built=“1″ fullwidth=“on“ _builder_version=“4.16″ da_disable_devices=“off|off|off“ global_colors_info=“{}“ da_is_popup=“off“ da_exit_intent=“off“ da_has_close=“on“ da_alt_close=“off“ da_dark_close=“off“ da_not_modal=“on“ da_is_singular=“off“ da_with_loader=“off“ da_has_shadow=“on“][et_pb_fullwidth_slider use_text_overlay=“on“ text_overlay_color=“rgba(6,66,58,0.25)“ _builder_version=“4.16″ custom_padding=“83px||65px|||“ auto=“on“ auto_ignore_hover=“on“ global_colors_info=“{}“][et_pb_slide heading=“Patienten“ use_bg_overlay=“off“ use_text_overlay=“on“ arrows_custom_color=“#2d788c“ dot_nav_custom_color=“#2d788c“ text_border_radius=“10px“ _builder_version=“4.16″ header_font=“|700|||||||“ header_text_align=“center“ body_text_align=“center“ body_font_size=“30px“ background_enable_color=“off“ use_background_color_gradient=“on“ background_color_gradient_direction=“90deg“ background_color_gradient_stops=“rgba(0,0,0,0) 0%|rgba(0,0,0,0) 100%“ background_color_gradient_overlays_image=“on“ background_color_gradient_start=“rgba(0,0,0,0)“ background_color_gradient_end=“rgba(0,0,0,0)“ background_image=“https:\/\/www.thervacb.eu\/wp-content\/uploads\/the-thervacb-vaccine-h.jpg“ background_enable_image=“on“ text_orientation=“center“ header_text_shadow_style=“preset1″ header_text_shadow_color=“#706f6f“ body_text_shadow_style=“preset1″ body_text_shadow_color=“#706f6f“ text_shadow_style=“preset1″ text_shadow_color=“#706f6f“ global_colors_info=“{}“ sticky_transition=“on“]<\/p>\n

Der TherVacB-Impfstoff<\/p>\n

[\/et_pb_slide][\/et_pb_fullwidth_slider][\/et_pb_section][et_pb_section fb_built=“1″ _builder_version=“4.16″ da_disable_devices=“off|off|off“ global_colors_info=“{}“ da_is_popup=“off“ da_exit_intent=“off“ da_has_close=“on“ da_alt_close=“off“ da_dark_close=“off“ da_not_modal=“on“ da_is_singular=“off“ da_with_loader=“off“ da_has_shadow=“on“][et_pb_row module_id=“timelines“ _builder_version=“4.16″ global_colors_info=“{}“][et_pb_column type=“4_4″ _builder_version=“4.16″ global_colors_info=“{}“][et_pb_text _builder_version=“4.25.0″ hover_enabled=“0″ global_colors_info=“{}“ sticky_enabled=“0″]<\/p>\n

Wann wird die Therapie f\u00fcr Patienten verf\u00fcgbar sein?<\/strong><\/h1>\n

Die oben vorgestellte klinische Studie ist Teil des EU-Projekts TherVacB. Es ist der erste Schritt, um die Sicherheit und Wirksamkeit der Therapie bei Menschen mit chronischer Hepatitis B zu testen. Wenn diese Studie erfolgreich ist, werden weitere klinische Studien (Phase II und III) folgen, um die klinische Entwicklung abzuschlie\u00dfen. Dies ist routinem\u00e4\u00dfig f\u00fcr neue medizinische Behandlungen erforderlich, bevor sie f\u00fcr die normale und regelm\u00e4\u00dfige Anwendung zugelassen werden k\u00f6nnen.
Wenn diese Versuche erfolgreich sind, k\u00f6nnte TherVacB der erste Impfstoff sein, der eine funktionelle Heilung von Hepatitis B erm\u00f6glicht.<\/p>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"

Der TherVacB-ImpfstoffWann wird die Therapie f\u00fcr Patienten verf\u00fcgbar sein? Die oben vorgestellte klinische Studie ist Teil des EU-Projekts TherVacB. Es ist der erste Schritt, um die Sicherheit und Wirksamkeit der Therapie bei Menschen mit chronischer Hepatitis B zu testen. Wenn diese Studie erfolgreich ist, werden weitere klinische Studien (Phase II und III) folgen, um die […]<\/p>\n","protected":false},"author":4,"featured_media":4931,"parent":7338,"menu_order":3,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":"","_links_to":"","_links_to_target":""},"class_list":["post-7348","page","type-page","status-publish","has-post-thumbnail","hentry"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.thervacb.eu\/de\/wp-json\/wp\/v2\/pages\/7348","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.thervacb.eu\/de\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.thervacb.eu\/de\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.thervacb.eu\/de\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.thervacb.eu\/de\/wp-json\/wp\/v2\/comments?post=7348"}],"version-history":[{"count":3,"href":"https:\/\/www.thervacb.eu\/de\/wp-json\/wp\/v2\/pages\/7348\/revisions"}],"predecessor-version":[{"id":12935,"href":"https:\/\/www.thervacb.eu\/de\/wp-json\/wp\/v2\/pages\/7348\/revisions\/12935"}],"up":[{"embeddable":true,"href":"https:\/\/www.thervacb.eu\/de\/wp-json\/wp\/v2\/pages\/7338"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.thervacb.eu\/de\/wp-json\/wp\/v2\/media\/4931"}],"wp:attachment":[{"href":"https:\/\/www.thervacb.eu\/de\/wp-json\/wp\/v2\/media?parent=7348"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}